In addition, the existence of pharmacological approaches targeting the nervous system to treat obesity, such as utilization of the glucagon-like peptide-1 receptor [9,20], go beyond the usage of the classical obesity-related pillars; exercise and diet [21] further indicate that the nervous system’s involvement in obesity development. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.